Information on Rheumatology Therapeutics

Welcome to the Rheumatology website of the Division of Anesthesia, Analgesia and Rheumatology Products (DAARP) at the Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration (FDA). This site provides information on available FDA-approved therapeutic treatments (drugs and biologics) for rheumatic diseases.This site is intended to be a resource for health care providers, patients, and clinical investigators.

This site is designed to give access to information regarding the current FDA regulatory review and approval process as it impacts the rheumatologic diseases included. Therefore, some therapies in widespread clinical use today are beyond the scope of this website.

We would like to hear from you concerning this web site. Please contact us.

• Rheumatology Therapeutics: Drugs and Biologics
• Rheumatology Therapeutics: Disease or Condition
• Information for Consumers and Patients
• Information for Investigators
• Arthritis Advisory Committee Information
• Clinical Trials Information
• Safety Information
• Additional Links